{
  "id": 2869,
  "text": "(2001).723.Sun, W., et al.Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy.BMC Cancer 15, 353 (2015).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: (2001).723.Sun, W., et al.Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy.BMC Cancer 15, 353 (2015).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有的研究和临床证据，对于接受根治性子宫切除术后的宫颈癌中等风险患者，联合拓扑替康和顺铂的放化疗相比单纯放疗，更具有潜在的临床优势。这种联合疗法通过增强对肿瘤细胞的杀伤作用，有望进一步降低肿瘤复发风险。然而，在选择治疗方式时，需要综合考虑患者的身体状况、治疗相关的毒性反应以及个体化风险评估。如果患者身体耐受性较好，联合放化疗可能是更优的选择；而对于某些耐受性较差或伴有其他合并症的患者，单纯放疗可能更为适合。因此，最终治疗方案需要在充分评估后，由多学科团队共同决定。",
  "query": "根据您提供的<text>，内容确实与宫颈癌有关，因此以下是符合要求的问题：\n\n在子宫颈癌患者进行根治性子宫切除术后，中等风险患者适合选择单纯放疗，还是联合拓扑替康和顺铂的放化疗？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据您提供的<text>，内容确实与宫颈癌有关，因此以下是符合要求的问题：\n\n在子宫颈癌患者进行根治性子宫切除术后，中等风险患者适合选择单纯放疗，还是联合拓扑替康和顺铂的放化疗？\n\n<reference text>: (2001).723.Sun, W., et al.Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy.BMC Cancer 15, 353 (2015).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有的研究和临床证据，对于接受根治性子宫切除术后的宫颈癌中等风险患者，联合拓扑替康和顺铂的放化疗相比单纯放疗，更具有潜在的临床优势。这种联合疗法通过增强对肿瘤细胞的杀伤作用，有望进一步降低肿瘤复发风险。然而，在选择治疗方式时，需要综合考虑患者的身体状况、治疗相关的毒性反应以及个体化风险评估。如果患者身体耐受性较好，联合放化疗可能是更优的选择；而对于某些耐受性较差或伴有其他合并症的患者，单纯放疗可能更为适合。因此，最终治疗方案需要在充分评估后，由多学科团队共同决定。"
}